| Execution period | 6 months from 01-10-2026 |
|---|
BSE filing, NSE: IKIO. Summary written from the filing by ALFA Finder's alert engine.
IKIO Technologies Ltd: key numbers
- Share price
- ₹173.90
- Market cap
- ₹1,344 Cr
- Revenue (annual)
- ₹595.3 Cr
- Net profit (annual)
- ₹37.83 Cr
- P/E (TTM)
- 28.9×Sector 43.7×
- Promoter holding
- 72.55%+0.00% QoQ
- FII holding
- 0.61%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from IKIO Technologies Ltd
All →IKIO Technologies Q2 FY27 Results: Net Profit ₹12.9 Cr, Up 18.3% YoY
IKIO Technologies Ltd reported revenue from operations of ₹208.7 Cr (+27.1% YoY) and net profit of ₹12.9 Cr (+18.3% YoY) for Q2 FY27.
- Key figure
- Net profit ₹12.9 Cr · +18.3% YoY
IKIO Technologies Board Meeting Date
IKIO Technologies has scheduled a board meeting on 5 November 2026 to consider unaudited standalone and consolidated quarterly results for September 2026. This is an advance notice; the results are not yet approved.
IKIO Technologies Other Announcement
IKIO Technologies filed its Reg 76 Reconciliation of Share Capital Audit Report for the quarter ended 30 September 2026. It is a routine compliance certificate with no transaction or business impact.
IKIO Technologies Business Update
IKIO Technologies' subsidiary, Royalux FZCO, entered a one-year vendor exclusivity undertaking with Danube Home LLC, targeting AED 2 million in potential business opportunities.
- Execution
- 1 year
IKIO Technologies Management Change
IKIO Technologies Limited announced the resignation of Assistant Vice President Nripendra Kumar Gupta and the appointment of Naveen Bhatia as Finance Head.
IKIO Technologies Price Movement Clarification
IKIO Technologies clarified that the recent increase in its stock trading volume is market-driven. The company confirmed it has no pending material information for disclosure.
Other other announcement announcements
All →Kiri Industries Other Announcement
Kiri Industries filed the Crisil monitoring agency report for the quarter ended September 30, 2026. The report covers utilisation of preferential warrant issue proceeds with no deviations.
Sahajanand Medical Technologies Other Announcement
Sahajanand Medical Technologies appointed Amit Jaste & Associates as Secretarial Auditor for 60 months, effective 5 November 2026. Approved at the same-day board meeting.
- Execution
- 60 months
Dr. Agarwals Health Care Other Announcement
Dr. Agarwal's Health Care submitted ICRA's monitoring agency report for the quarter ended September 30, 2026. ICRA reports no material deviation in IPO proceeds utilisation.
Span Divergent Other Announcement
Span Divergent approved leasing Ahmedabad property to material subsidiary Dryfruit Factory LLP. Rent is capped at ₹3 lakh monthly under an arm's-length related-party transaction.
Cello World Other Announcement
Cello World's QIP monitoring report shows no fund deviation for the quarter ended September 2026. Object 1 is delayed, with Rs.1.51 crore unutilised.
Finkurve Financial Services Other Announcement
Finkurve Financial Services filed its Regulation 52(7) statement on use of Rs. 26 crore from its NCD issue, quarter ended September 2026. The statement reports no deviation or variation in use of proceeds.